Pure Global

Extracorporeal Shockwave Therapy in Insertional Achilles Tendinopathy - Trial NCT03683641

Access comprehensive clinical trial information for NCT03683641 through Pure Global AI's free database. This phase not specified trial is sponsored by Mahidol University and is currently Completed. The study focuses on Insertional Achilles Tendinopathy. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT03683641
Completed
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT03683641
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Extracorporeal Shockwave Therapy in Insertional Achilles Tendinopathy

Study Focus

Extracorporeal Shock Wave Therapy

Interventional

device

Sponsor & Location

Mahidol University

Timeline & Enrollment

N/A

Jul 04, 2016

Jul 31, 2018

30 participants

Primary Outcome

Visual Analog Scale

Summary

There is still limited number of studies in the literature provides insufficient evidence to
 support the use of ESWT in the treatment of insertional Achilles tendinopathy and the
 contribution of a placebo effect to the shock waves was not assessed by previous study. So
 the investigators conducted a double-blinded randomized-controlled trial at the orthopedic
 out-patient clinic, Department of Orthopedics, Faculty of Medicine Ramathibodi Hospital
 between December 2016 and June 2018. Hypothesized that ESWT might be effective on insertional
 Achilles tendinopathy

ICD-10 Classifications

Achilles tendinitis
Injury of Achilles tendon
Short Achilles tendon (acquired)
Spontaneous rupture of unspecified tendon
Injury of unspecified muscle and tendon at ankle and foot level

Data Source

ClinicalTrials.gov

NCT03683641

Device Trial